Alkem Labs Gains As U.S. FDA Conducts Audit At Daman Plant – Shares of the Mumbai-based drug maker rose as much as 2.1 percent t0 Rs 2,150 as U.S. drug regulator conducts a surprise audit at its largest facility in Daman, two people aware of the development told BloombergQuint requesting anonymity.
- Rupee Falls Below 90/USD: What This Big Slide Means for India Now
- Copper Prices Jump to Four-Month High as Supply Gets Tight — Prices Set for More Upside
- Wockhardt Share Jumps 19% on Heavy Buying — Why the Pharma Stock is Rising Today
- Spot Silver Above $56.10: Big Target $60–$62; MCX Silver Hits Fresh 52-Week High
- MCX Copper Price Forecast: Buy or Sell? Neal Bhai Explains the Next Big Move
The U. S. Food and Drug Administration officials began inspecting the site yesterday, which is expected to go on for another four to five days, the two people quoted aboved said. The officials are mainly auditing the quality control practices and production line of the Mumbai-based drug maker.
Read More: Stocks To Watch: Amtek, Dalmia Bharat, Fortis, JSPL, TCS
Disclaimer
This article is intended for educational purposes only. The views and opinions expressed are those of individual analysts or brokerage firms and do not represent the views of GoldSilverReports.com. Investors are strongly advised to consult certified financial experts before making any investment or trading decisions.
| Follow us on |
| Telegram, Whatsapp , Facebook, Twitter, Instagram, YouTube, Google Business Profile and Truth Social. |